• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problem Torn Material (3024)
Patient Problem Aortic Regurgitation (1716)
Event Date 01/18/2018
Event Type  Injury  
Event Description
A 21 mm trifecta valve was implanted in the aortic position, on (b)(6) 2014, during a double valve replacement due to aortic stenosis with regurgitation.A 27 mm epic valve was implanted in the mitral position due to mitral stenosis with regurgitation.In (b)(6) 2017, the patient presented at the hospital due to cardiac failure.A clinical examination was conducted and structural valve deterioration of the trifecta valve was confirmed.On (b)(6) 2018, re-do avr was performed and the trifecta valve was explanted.Upon explant of this valve, a tear was observed from the stent post shared with a left coronary cusp (lcc) and a right coronary cusp (rcc) toward the lcc side.Subsequently, a 19 mm carpentier-edwards perimount magna ease aortic heart valve was implanted.The patient was reported to be in stable condition postoperatively.Reportedly, the patient was treated with antibiotic due to infective endocarditis in 2006, then recovered after medication.There were no anomalies reported on the epic valve which remains implanted.During explant of the trifecta valve, damage was reported to the sewing cuff consistent with fracture.
 
Manufacturer Narrative
The reported event of a tear was confirmed.Morphological and histopathological examination found leaflets 1 and 3 were torn, and all three leaflets contained fibrous pannus ingrowth on their inflow surfaces.No acute inflammation or significant calcifications were found.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the torn leaflet tissue remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
Manufacturer (Section G)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR   31310-260
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key7277748
MDR Text Key100303469
Report Number3001883144-2018-00024
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date04/07/2016
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number4652012
Other Device ID Number05414734052023
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/02/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/19/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/09/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age77 YR
Patient Weight47
-
-